American Cancer Society. (2013, October 7). Leukemia - Acute Lymphocytic (Adults). Atlanta, GA: American Cancer Society.
Drugs and Health Products, Health Canada. (2018, March 14). Regulatory Decision Summary: Besponsa. Extrait de: https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?linkID=RDS00349.
Goekbuget N, Hoelzer D. Diagnosis and Treatment of adult acute lymphoblastic leukemia. Wiernik PH, Goldman JM, Dutcher JP & Kyle RA (eds.). (2013). Neoplastic Diseases of the Blood. (5th Édition). Springer. 20: pp. 331-354.
Health Canada, Drugs and Health Products. (2015, November 13). Blincyto (blinatumomab) Authorization with Conditions. Extrait de: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/notices-avis/conditions/blincyto_dhcpl_lapds_181723-eng.php.
Kebriaei P, Champlin R, de Lima M, et al. Management of acute leukemias. DeVita VT Jr, Lawrence TS, & Rosenberg SA. (2014, March 7). Cancer: Principles & Practice of Oncology. (9th Édition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 131: pp. 1928-1954.
Kurtin SE. Leukemia and myelodysplastic syndromes. Yarbro, CH, Wujcki D, & Holmes Gobel B. (eds.). (2011). Cancer Nursing: Principles and Practice. (7th Édition). Sudbury, MA: Jones and Bartlett. 57: pp. 1369-1398.
National Cancer Institute. (2014, February 21). Adult Acute Lymphoblastic Leukemia Treatment (PDQ®) Health Professional Version. Bethesda, MD: National Cancer Institute.×